Suppressive Effects of Valsartan on Microalbuminuria and CRP in Patients with Metabolic Syndrome (Val-Mets)-Reference-Cited by-同舟云学术

Suppressive Effects of Valsartan on Microalbuminuria and CRP in Patients with Metabolic Syndrome (Val-Mets)

Published:2011-01-26 Issue:2 Volume:33 Page:117-123
ISSN:1064-1963
Container-title:Clinical and Experimental Hypertension
language:en
Short-container-title:Clinical and Experimental Hypertension

Author:

Shishido Tetsuro,Konta Tsuneo,Nishiyama Satoshi,Miyashita Takehiko,Miyamoto Takuya,Takasaki Satoshi,Nitobe Joji,Watanabe Tetsu,Takeishi Yasuchika,Kubota Isao

Publisher

Informa UK Limited

Subject

General Medicine,Physiology,Internal Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/10641963.2010.531837

Reference44 articles.

1. Prospective analysis of the insulin-resistance syndrome (syndrome X)

2. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

3. NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older

4. Metabolic Syndrome - Definition and Diagnostic Criteria in Japan

5. The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-aged Men

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of sacubitril/valsartan in an outpatient setting: A single-center real-world retrospective study in HFrEF patients with focus on possible predictors of clinical outcome;Advances in Clinical and Experimental Medicine;2022-01-29

2. Azilsartan medoxomil for improving insulin resistance and adipokine levels in hypertension in comparison with angiotensin-converting enzyme inhibitors;Russian Journal of Cardiology;2020-08-15

3. Effectiveness of in insulin resistance correction and the adipokines level reduction in patients with arterial hypertension in comparison with other ARBs;Russian Journal of Cardiology;2019-02-09

4. Long-term effects intensive medical therapy on the development and progression of subclinical atherosclerosis and the metabolic syndrome in Chinese patients with type 2 diabetes mellitus;Medicine;2016-11

5. The Effects of Valsartan and Amlodipine on the Levels of Irisin, Adropin, and Perilipin;Clinical Laboratory;2015